Uriarte MDF, Gómez GBA, Solís LG

Language: Spanish
References: 5
Page: 13-15
PDF size: 148.47 Kb.

ABSTRACT

Background: cutaneous leiomyosarcoma is a rare malignant neoplasm that originates mainly from the piloerector muscle and in some cases has been found at the genital level in muscle dartos, vulvar region and mammary areola.
Objective: to evaluate the epidemiological and clinical characteristics of cutaneous leiomyosarcomas in the Dermatological Institute of Jalisco Dr. José Barba Rubio, Mexico.
Material and method: a retrospective study was carried out from January 1, 1997 to December 31, 2017, in which patients diagnosed with cutaneous leiomyosarcoma were included, where the variables of frequency, age, gender, location and association with pain were collected.
Results: 19 cases of cutaneous leiomyosarcoma were reported, 10 of them were men (52%) and nine women (48%). The age range ranged from 11 to 91 years with an average age of 55.10 years. He referred pain in six (31%). Tumors mainly affected upper extremities in 12 cases (63%).
Conclusions: cutaneous leiomyosarcomas are rare tumors, reason for which the present study allows to know the most important characteristics of the same.

REFERENCES

1. Dias-Negrão Murback N, Takita LC, Corrêa de Castro B y Filho GH, Cutaneous leiomyosarcoma on the face, Ann Bras Dermatol 2018; 93(2):262-4.

2. Rodríguez-Lamba E, Molina-López I, Parra-Blanco E, Suárez-Fernández R y Pulido-Pérez A, Leiomiosarcoma cutáneo: características clínicas, histopatológicas y correlación pronóstica en 12 pacientes, Act Dermosifiliogr 2018; 109(2):140-3.

3. Marhx-Gama N y Guevara-Gutiérrez E, Tumores cutáneos de músculo liso: características epidemiológicas y clínicas, Dermatol Rev Mex 2011; 55(2): 69-72.

4. Castro E y Asato C, Leiomiosarcoma superficial recurrente y mestastásico: reporte de caso y revisión de la literatura, Folia Dermatol Peru 2005; 16:140-4.

5. Svarvar C, Böhling T, Berlin O, Gustafson P et al., Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group, Cancer 2007; 109:282-91.